NHS Scotland will offer the new drug to protect babies born before 32 weeks against respiratory syncytial virus.

The NHS is set to roll out a single, long-lasting injection this autumn to protect premature and vulnerable babies from respiratory syncytial virus (RSV). The jab offers a vital “protective bubble” ...

The RSV vaccination programme in Northern Ireland is to be extended to cover premature babies from autumn 2025. | UTV News ...

Public health minister Jenni Minto said the jab would be available for babies born before 32 weeks to protect them over the ...

RSV is a respiratory virus that usually causes mild, cold-like symptoms in adults and children, however the severity of ...

Adults over 50 and those with chronic conditions are at risk too. Learn how to protect yourself and where to go for more information.

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...

Common cold coronavirus incidence decreased by more than half after widespread SARS-CoV-2 infections and vaccination compared ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Vaccination of pregnant women int he UK has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests.

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...